August 2015 Br J Cardiol 2015;22:96–7
Heather Wetherell
This issue, we have a little teaser for GPs, who may reasonably come across this kind of electrocardiogram (ECG) any day of the week. Figure 1 shows the ECG of a well, 83-year-old woman, who attended her GP’s surgery for her ‘annual review’. As part of this review, the practice nurse carried out a routine ECG. Figure 1. The electrocardiogram obtained during the annual review Believe or not, it’s possible to answer the following three questions from this ECG: Q1: What chronic condition was being monitored at her annual review? Q2: What is she taking for this condition? Q3: What action should the GP take now? Let’s go through the ECG
November 2014 Online First
BJCardio Staff
X-VERT: rivaroxaban▼ an alternative to VKA in cardioversion for AF Watch Professor Keith Fox, Chairman of the ESC programme committee discussing the relevance of X-VERT and other studies for UK practice in our podcast from the ESC Oral anticoagulant therapy with rivaroxaban is an alternative to vitamin K antagonists (VKAs) in patients with AF who are undergoing elective cardioversion according to the results of the X-VERT study.1 In addition, rivaroxaban may potentially have one important advantage over VKAs, with a shorter time to cardioversion, the study suggests. Professor Riccardo Cappato (University of Milan, Italy), the co-principal
December 2013 Br J Cardiol 2013;20:160
Dr John Havard; Dr John Soong
National survey of patients with AF in the acute medical unit: a day in the life survey Dear Sirs, The first national survey examining the management of atrial fibrillation (AF) within acute medical units up and down the country has just been published in the British Journal of Cardiology.1 Essentially it seems to show that secondary care is just as bad as primary care in initiating warfarin for AF patients. This group of patients is five times more likely to have a thromboembolic cerebrovascular accident than matched populations in sinus rhythm and yet doctors are ineffective at influencing change. This study took place over a 24-hour period
July 2013 Br J Cardiol 2013;20:106 doi:10.5837/bjc.2013.021 Online First
John Soong, Anjali Balasanthiran, Donald C MacLeod, Derek Bell
Introduction Atrial fibrillation (AF) is the most common cardiac dysrrhythmia, whose sequelae include stroke, heart failure and poor quality of life.1 In parallel with an ageing population, the prevalence of AF is increasing, with persistent or permanent forms affecting 10–15% of the population over the age of 75 years.2-6 The effective management of AF has been a source of recurring debate, leading to the publication of combined American College of Cardiology/American Heart Association/European Society of Cardiology (ACC/AHA/ESC), and National Institute for Health and Clinical Excellence (NICE) guidelines in 2006.7,8 In addition to evidenc
June 2002 Br J Cardiol 2002;9:356-7
Arpandev Bhattacharyya, Manju Bhavnani, David James Tymms
(more…)
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits